Moderna Set To Test Potential Coronavirus Vaccine With 30,000 Volunteers

A vaccine against COVID-19 developed by US biotech firm Moderna will enter the third and final stage of its clinical trial in July with 30,000 participants, the manufacturer has announced. Moderna, co-founded and chaired by Noubar Afeyan said it already has made ...